Parameter
| Biomarker | GALAD model (age + sex +AFP+AFP-L3+DCP) | Full name | Gender, Age, AFP-L3, AFP, DCP | Molecular Type | Composite index (protein + clinical parameters) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Diagnosis, prognosis, | ||
| Disease | Hepatocellular Carcinoma (HCC) | Disease Subtypes | / | ||
| Organ | Liver | Test Sample / Technology Platform | Serum (ELISA+ algorithm analysis) | ||
| Pathobiological Mechanisms | To improve the specificity and sensitivity of HCC diagnosis by integrating multi-dimensional parameters | ||||
| Clinical Availability Status | In clinical practice, clinical validation: better than single marker, for early HCC detection efficiency | ||||
| Notes and Dynamics | Multi-center clinical validation is underway, and it is expected to become a standardized screening tool | ||||